Insights

Innovative Genetic Medicines 4D Molecular Therapeutics is pioneering innovative genetic medicines to treat a wide range of diseases, presenting a compelling sales opportunity for healthcare providers looking to offer cutting-edge treatments to their patients.

Expanding Clinical Pipeline With five product candidates in clinical trials for seven patient populations, 4D Molecular Therapeutics' continuous expansion of its clinical pipeline opens up avenues for pharmaceutical companies and research institutions to collaborate on developing novel therapies.

Strategic Partnerships & Licensing The recent partnership with Astellas and other strategic collaborations showcase 4D Molecular Therapeutics' commitment to leveraging its proprietary technologies. This presents an ideal sales opportunity for companies looking to access their vector platforms for addressing rare ophthalmic targets.

Financially Stable & Well-Funded With revenues ranging from $10M to $50M and securing $300M in funding, 4D Molecular Therapeutics boasts financial stability. This financial robustness can appeal to potential investors, creating avenues for financial service providers and investment firms seeking partnership opportunities.

Top Talent & Industry Leaders 4D Molecular Therapeutics' team comprises top talent in the industry, exemplified by the appointment of industry veteran Uneek Mehra as the Chief Financial & Business Officer. This positions the company as an attractive partner for talent recruitment agencies and executive search firms.

4D Molecular Therapeutics Tech Stack

4D Molecular Therapeutics uses 8 technology products and services including Power BI, Microsoft Word, RSS, and more. Explore 4D Molecular Therapeutics's tech stack below.

  • Power BI
    Business Intelligence
  • Microsoft Word
    Editors
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Kinsta
    Platform As A Service
  • Amazon Web Services
    Platform As A Service
  • Yoast SEO
    Search Engines

Media & News

4D Molecular Therapeutics's Email Address Formats

4D Molecular Therapeutics uses at least 1 format(s):
4D Molecular Therapeutics Email FormatsExamplePercentage
flast@4dmoleculartherapeutics.comJDoe@4dmoleculartherapeutics.com
87%
first.last@4dmoleculartherapeutics.comJohn.Doe@4dmoleculartherapeutics.com
11%
last.first@4dmoleculartherapeutics.comDoe.John@4dmoleculartherapeutics.com
1%
fl@4dmoleculartherapeutics.comJD@4dmoleculartherapeutics.com
1%

Frequently Asked Questions

Where is 4D Molecular Therapeutics's headquarters located?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's main headquarters is located at 5858 Horton St 455 Emeryville, California 94608 US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is 4D Molecular Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact 4D Molecular Therapeutics's main corporate office by phone at +1-510-505-2680. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is 4D Molecular Therapeutics's stock symbol?

Minus sign iconPlus sign icon
4D Molecular Therapeutics is a publicly traded company; the company's stock symbol is FDMT.

What is 4D Molecular Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's official website is 4dmoleculartherapeutics.com and has social profiles on LinkedIn.

How much revenue does 4D Molecular Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2024, 4D Molecular Therapeutics's annual revenue reached $35M.

What is 4D Molecular Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 4D Molecular Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, 4D Molecular Therapeutics has approximately 190 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include CSO: A. R.Chief Medical Officer: R. K.Chief Development Officer Cdo: A. S.. Explore 4D Molecular Therapeutics's employee directory with LeadIQ.

What industry does 4D Molecular Therapeutics belong to?

Minus sign iconPlus sign icon
4D Molecular Therapeutics operates in the Biotechnology Research industry.

What technology does 4D Molecular Therapeutics use?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's tech stack includes Power BIMicrosoft WordRSSOpen GraphMicrosoftKinstaAmazon Web ServicesYoast SEO.

What is 4D Molecular Therapeutics's email format?

Minus sign iconPlus sign icon
4D Molecular Therapeutics's email format typically follows the pattern of . Find more 4D Molecular Therapeutics email formats with LeadIQ.

How much funding has 4D Molecular Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, 4D Molecular Therapeutics has raised $300M in funding. The last funding round occurred on Feb 06, 2024.

When was 4D Molecular Therapeutics founded?

Minus sign iconPlus sign icon
4D Molecular Therapeutics was founded in 2013.
4D Molecular Therapeutics

4D Molecular Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Our vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Our product design, development and manufacturing engine empowers us to efficiently create our valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. We have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations.

We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our 4 Guiding Principles drive the way we work together: 
-	Dare to Cure
-	Break Boundaries 
-	Beyond Yourself 
-	Prepare & Executive Relentlessly 

Join us in creating the future of genetic medicine.

Section iconCompany Overview

Headquarters
5858 Horton St 455 Emeryville, California 94608 US
Phone number
+1-510-505-2680
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
FDMT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $300M

    4D Molecular Therapeutics has raised a total of $300M of funding over 6 rounds. Their latest funding round was raised on Feb 06, 2024.

  • $10M$50M

    4D Molecular Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $300M

    4D Molecular Therapeutics has raised a total of $300M of funding over 6 rounds. Their latest funding round was raised on Feb 06, 2024.

  • $10M$50M

    4D Molecular Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.